Flu vaccine safety study for adults 65 and older
Part of Infections, Lungs & breathing clinical trials.
This study checks the safety of a flu vaccine called Efluelda Tetra in adults aged 65 and older. If you are getting this vaccine, you may be able to join and help monitor its safety.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 65 years of age or older on the day you join.
- You have signed and dated the consent form.
- You are receiving one dose of Efluelda Tetra on the day you join.
- You have not taken part in this study before.
- You are not currently in another clinical study (or have not been in the last 4 weeks) involving a vaccine, drug, device, or procedure.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at getting an influenza (flu) vaccine in adults age 75 and older. It may help doctors understand how to safely give flu shots to older adults.
This study checks how well the seasonal flu vaccine works in people 65 and older who have had flu shots regularly. It compares their immune response to that of younger adults to see if repeated vaccination still protects them.
This study monitors the safety of the high-dose flu vaccine Efluelda in adults 65 and older. It helps ensure the vaccine is safe for people in this age group.
This trial tests an influenza (flu) vaccine in people aged 60 and above. It aims to see if the vaccine is safe and works well for older adults, who are at higher risk for flu complications.
This study tests a new flu vaccine in adults aged 65 and older to see how well it prevents the flu. If you are generally healthy or manage chronic conditions well, you may be able to join.
This study tests a new seasonal flu shot for people aged 60 and older. It aims to see if the vaccine is safe and how well it produces a protective immune response in older adults.
Hear when a new Immunization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.